Dr A Srinivas Kumar

Dr. A. Sreenivas Kumar is a renowned senior interventional cardiologist with over 25 years of experience at Apollo Hospitals, Hyderabad. He specialises in complex coronary procedures, device therapies, and interventional management of structural heart diseases. Dr. Kumar has played a key role in advancing interventional cardiology practices in South India and is a well-respected teacher and speaker at national cardiology conferences. His clinical acumen and commitment to patient care have earned him a stellar reputation among peers and patients alike.

Educational Qualifications:

• MBBS – Osmania Medical College, Hyderabad, completed in December 1989
• MD (General Medicine) – Osmania Medical College, Hyderabad, completed in June 1994
• DM (Cardiology) – Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, completed in June 1998
• FACC (Fellow of the American College of Cardiology) – Awarded at ACC, Chicago, 2008

Professional Experience:

• Director, Clinical Research, Care Group Hospitals, India.
• Founder Director, TCT India, South Asia.
• Chairman, Cardio Vascular Sciences & Chief Cardiologist, Citizens Hospitals, Hyderabad.
• Director Cardiac Cathlab, Senior Interventional Cardiologist Care Hospitals-Hyd.

Professional Memberships:

• Chairman, Facts Professional Services (FPS) & Founder, Director & CEO - FACTS – Fraternity of Advanced Cardiovascular Techniques & solutions- FPS- Largest CV professional group of India
• Founding Course Director – Advance Cardio-vascular Solutions – India (ACVS – INDIA)/ TCT INDIA, South Asia Conference.- India’s Premier Interventional Experience
• Chairman, Cardiology Society of India – National Intervention Council (CSI-NIC) 2017-2019
• Founder Director, TCT India, South Asia
• Indian Medical Association
• Cardiology Society of India (CSI)
• ACC, AMA, API, IMA.

Trainings and Certifications:

• Selected as reviewer for International Journal “Catheterisation & Cardiovascular Diagnosis’’ in 1998.

• Founder Editor of National Medical Journal “Post Graduate Medical Clinics of Osmania’’.

Awards and Achievements:

• S. R. Rao Research Award for best thesis in M.D. General Medicine “A study of clinical profile of cases of Sickle cell disorder in adults”.

• State 2nd Rank in Andhra Pradesh MBBS Entrance Examination

Publications:

• Immediate and follow-up results of Inoue balloon mitral valvotomy in juvenile rheumatic mitral stenosis. N. Sinha A.Kapoor, A.Sreenivas Kumar, M.Shahi, S.Radhakrishnan, S.Shrivastava, P.K.Goel. Journal Of Heart Valve & Disease, 1997, 6:6.
• Influence of Subvalvular pathology on immediate results and follow up events of Inoue balloon mitral valvotomy.  A. Sreenivas Kumar, A. Kapoor, N.Sinha, S. Tewari, P.K.Goel, C.V. Umeshan, M.Shahi.  Accepted for publication in Int. J. cardiol.
• Small aortic annulus: A Functional definition. Probal .K.Ghosh, Sanjeev Kumar, Shantanu Pandey, A.Sreenivas Kumar, N.Sinha, M.Shahi. Annals of Asian cardiovascular and thoracic surgery October 98.
• Small (<21mm) aortic valve prostheses - A clinical and Hemodynamic evaluation.  A.Sreenivas Kumar, Prabhat Kumar, M.Shahi, N.Sinha, Sanjeev Kumar, Shantanu Pandey, ProbalK.Ghosh.  Journal of Heart Valve Disease 98..
• Periodic Intermittent Electromechanical Dissociation:Hemodynamic Correlate of a Malfunctioning Mechanical Prostheses Letter to the Ed.  P.K.Goel, M.Shahi, A.Sreenivas Kumar, R.K.Singh..  Cath Cardiovasc. Diagn. Nov.97.

• PRINCIPAL INVESTIGATOR- RE-DEEM STUDY – RandomisEd Dabigatran Etexilate dose finding study in patients with Acute Coronary syndromes post index Event with additional risk factors for cardiovascular complications also receiving asprin and clopidogrel: Multicentre, prospective , placebo controlled, group dose escalation trial-Sponsored by Boehringer Ingelheim.- 2nd leading recruiter in the world.

• CO-INVESTIGATOR - a multinational, multicentre, randomized, parallel group, Double-blind study to assess the efficacy and safety of 1 mg, 5 Mg and 20 mg tid of oral sildenafil in the treatment of Subjects aged 18 years and over with pulmonary arterial Hypertension (PAH)- A Multicentre PAH study sponsored by Pfizer Int. Ltd.- Leading recruiters in the world.

• PRINCIPAL INVESTIGATOR for Nephric –II Study – A Randomized Comparison of Iapamiro vs. Iopamidal in Diabetic Renal Insufficiency patients- Sponsored by GE Health Care. –Appreciated as Worlds leading recruiter for enrolling maximum no of patients.

• PRINCIPAL INVESTIGATOR – COREL C Multicentre Stent Study- Paclitaxel eluting, Non-polymeric, Nonporous carbon-carbon coated Cobalt-chromium stent: Clinical and Angiographic Evaluation. Sponsored by Relysis India Pvt. Ltd. - 2nd leading recruiter for the study.

• PRINCIPAL INVESTIGATOR- SPIRIT WOMEN CLINICAL EVALUATION : A Clinical Evaluation of the Xience-V Everolimus eluting coronary stent system in the treatment of women with denovo coronary artery lesion (single arm study protocol) – Leading recruiter in the world.

• PRINCIPAL INVESTIGATOR –Xience-V Everolimus eluting coronary stent system (EECSS) India- Post marketing Registry- appreciated for faster enrollment rate per month.

• PRICIPAL INVESTIGATOR – AMI- Stem cell study – A Randomized, double blind Multicentric, Placebo controlled , Single dose , Phase-II Study assessing the safety and efficacy of Intravenous ex vivo cultured adult allogenic mesenchymal stem cells in patients with STEMI.- Sponsored by STEMPEUTICS Research Ltd.

• CO-INVESTIGATOR. – A Randomized, double blind Multicentric , Placebo controlled , Single dose , Phase-II Study assessing the safety and efficacy of Intramuscular ex vivo cultured adult allogenic mesenchymal stem cells in patients with Critical Limb Ischemia.- Sponsored by STEMPEUTICS Research Ltd.

• PRINCIPAL INVESTIGATOR).- prospective Evaluation of Advanced Glycosylation End-products in chronic heart failure patients - Type II DM with stable Heart failure patients ( Phase II)

• CO-INVESTIGATOR - ART (Arterial Revascularisation Trial) ART is a multi-centre, international, randomized trial evaluating whether the use of both mammary arteries during coronary artery bypass grafting (CABG) improves survival, and reduces the chance of recurrent chest pain and/or the need for further intervention (including surgery) compared to using one mammary artery. ART is supported by grants from the Medical Research Council and the British Heart Foundation.Evaluation of acute safety and efficacy of the Basal Annuloplasty Cardia Externally devise in the treatment of Functional Mitral valve Regurgitation ( Phase II )- Experienced in dp/ dt,

• Experienced in Tissue Doppler Echocardiography.Multicenter Evaluation of Coronary Dual Source CT angiography in patients with Intermediate Risk of Coronary Artery Stenosis- Leading recruiters in World. CEC MEMBER – BIOFLOW- INDIA.

• Immediate and follow up results of Inoue balloon mitral valvotomy in juvenile rheumatic mitral stenosis. N. Sinha A.Kapoor, A.Sreenivas Kumar, M.Shahi, S.Radhakrishnan, S.Shrivastava, P.K.Goel. Journal Of Heart Valve & Disease, 1997, 6:6.

• Influence of Subvalvular pathology on immediate results and follow up events of Inoue balloon mitral valvotomy. A. Sreenivas Kumar, A. Kapoor, N.Sinha, S. Tewari, P.K.Goel, C.V. Umeshan, M.Shahi. Accepted for publication in Int. J. cardiol. Small aortic annulus: A Functional definition. Probal .K.Ghosh, Sanjeev Kumar, Shantanu Pandey, A.Sreenivas Kumar, N.Sinha, M.Shahi. Annals of Asian cardiovascular and thoracic surgery October 98.Small (<21mm) aortic valve prostheses - A clinical and Hemodynamic evaluation. A.Sreenivas Kumar, Prabhat Kumar, M.Shahi, N.Sinha, Sanjeev Kumar, Shantanu Pandey, Probal K.Ghosh. Journal of Heart Valve Disease 98..Periodic Intermittent Electromechanical Dissociation:Hemodynamic Correlate of a Malfunctioning Mechanical Prostheses Letter to the Ed. P.K.Goel, M.Shahi, A.Sreenivas Kumar, R.K.Singh.. Cath Cardiovasc. Diagn. Nov.97.

‍